U.S. 10Y touches 5%, AI stocks tumble and oil stays above US$105 markets brace for tomorrow’s Fed decision Global markets enter Tuesday with three pressure points converging: U.S. borrowing costs briefly crossed 5%, oil remains above US$100, and the AI trade suffered a sharp reset overnight . The S&P 500, Dow and Nasdaq all closed lower Monday, while the Philadelphia semiconductor index plunged 5.9% . For Malaysian investors, there was one encouraging counterpoint: the FBM KLCI rebounded 0.66% to 1,698.01 , snapping four consecutive losing sessions despite the difficult global backdrop. 30-second market snapshot Market / Asset Latest 🇺🇸 S&P 500 7,619.98, -0.48% 🇺🇸 Dow Jones 52,421.20, -0.29% 🇺🇸 Nasdaq 26,186.41, -0.56% 🇲🇾 FBM KLCI 1,698.01, +0.66% 💵 USD/MYR ~4.04–4.05 🇺🇸 U.S. 10Y Treasury briefly >5%; ~4.98% later 🥇 Spot gold ~US$4,313/oz, -0.8% 🛢️ Brent US$105.68/bbl, +~1% ₿ Bitcoin ~US$79,150, +~2% Monday The dollar strengthened Mo...
Revenue Surges 26% on Strong Healthcare Demand, Acquisitions
- IHH Healthcare Bhd (KL:IHH) reported a slight increase in net profit to RM732 million for 4QFY2024, up from RM728 million a year earlier.
- Quarterly revenue jumped 26.5% to RM6.69 billion, fueled by:
- Higher inpatient volumes and revenue intensity from more complex cases.
- The consolidation of Timberland Medical Centre and Island Hospital post-acquisition.
Dividend Payout Increased
- Final dividend declared: 5.5 sen per share, payable on April 28.
- Total FY2024 dividend: 10 sen per share, up from 9 sen per share in FY2023.
- Dividend payout ratio: 40% of profit after tax and minority interests (Patmi), exceeding the 30% policy threshold.
Financial Performance Breakdown
- Earnings before interest, taxes, depreciation, and amortisation (EBITDA) rose 33% YoY to RM1.4 billion.
- Excluding MFRS 129 effects (hyperinflation adjustments in Türkiye), revenue and EBITDA would have grown 13% and 9% YoY, respectively.
- Cost pressures impacted profitability, with:
- Staff costs up 33% YoY to RM2.59 billion.
- Finance costs surging 38% YoY to RM341 million.
- Depreciation and impairment charges rising 37% YoY to RM372 million.
Full-Year Profit Declines Despite Revenue Growth
- FY2024 net profit fell 10% to RM2.66 billion, impacted by:
- Foreign exchange losses.
- Higher staff and depreciation costs.
- Annual revenue grew 16% to RM24.38 billion, driven by sustained healthcare demand across key markets.
Optimistic Outlook: Expansion Plans and Strategic Growth Priorities
- IHH to add nearly 4,000 new beds over the next four years to meet rising demand.
- Plans to enhance profitability while mitigating inflationary and interest rate risks.
- Focus on high-value, cost-effective healthcare and improving clinical outcomes.
- CEO Dr. Prem Kumar Nair: Confident in strengthening IHH’s position as a global healthcare leader while delivering healthy returns to shareholders.
Stock Performance
- IHH shares closed at RM7.31 on Thursday, gaining one sen.
- Market capitalisation: RM64.35 billion.
- Stock has climbed roughly 17% since August 2024.
Comments
Post a Comment